Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones10-27

DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 1.48% to $3.99 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.82% to 26,169.38 and the Dow Jones Industrial Average rising 0.28% to 52,361.58.

This was the stock's sixth consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 77.97% short of its 52-week high of $18.11, which the company reached on October 28th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.75% to $3.94, Fortress Biotech Inc. (FBIO) fell 3.11% to $1.87, and Viking Therapeutics Inc. (VKTX) fell 0.78% to $24.21.

Trading volume (847,346) remained 159,578 below its 50-day average volume of 1.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 26, 2026.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment